Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
Add more filters










Publication year range
1.
Anticancer Res ; 32(1): 373-81, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22213329

ABSTRACT

UNLABELLED: It has been demonstrated in several studies that serum calcidiol (25 OH vitamin D(3)) concentration is in a reversed and linear relationship with cancer risk. However, there are also studies showing no such association and some even suggest the opposite. The risk of pancreatic and oesophageal cancer seems to increase, when serum calcidiol concentration increases. A bias in these studies might be that their basic assumption is linear dependence of cancer on serum calcidiol concentration. Some studies suggest a U-shaped association between the disease and the serum calcidiol concentration. Evidence, in the literature, of the relationship between serum calcidiol concentration and disease is reviewed and an optimal level of 40-80 nmol/L (16-32 ng/ml) is suggested. Serum calcidiol seems to be a better predictor of cancer development than calcitriol (1α, 25 (OH)(2) vitamin D(3)). A calcidiol insufficiency, as well as an insufficient solar exposure, is associated with an increased risk of several solid carcinomas. In a recent study, our group demonstrated that calcidiol is an active hormone in CYP24 (24-hydroxylase) deficient cells. In these cells, calcidiol and calcitriol act synergistically, therefore fluctuations of the serum calcidiol concentration may define the hormonal activity and cancer development. CONCLUSION: Serum calcidiol concentration and the risk of many common diseases and aging phenomena seem to show a U-shaped association suggesting a lower and upper limit for healthy serum calcidiol concentration. An imbalance of hormonal calcidiol rather than that of calcitriol is a risk factor in carcinomas and chronic diseases, which might be prevented by an optimal serum calcidiol concentration. Multiple daily dosing of cholecalcipherol or skin patches could best provide an optimal dosing and stable serum concentration. Alternatively, narrow-band UV-B lamps are a possible optimal solution, when given by trained personnel.


Subject(s)
Calcifediol/blood , Neoplasms/blood , Neoplasms/prevention & control , Vitamins/blood , Humans
2.
Med Chem ; 2(5): 457-61, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17017984

ABSTRACT

Pancreatic cancer is one of the tumors with the highest mortality, poorly responding to available chemotherapeutic agents. The objective of this study was to study the anticancer effects of all-trans retinoid acid, a functional form of vitamin A, on pancreatic cancer cells. Human pancreatic cancer MiaPaCa-2 cells were treated with 1, 5, 10, 20, 30, 40 and 50 microM ATRA for 1, 2, 3, 4, 5 or 6 d, respectively. Cell growth was determined by MTT viability assay. The cell cycle distribution and the alkaline phosphatase (ALP) activity were analyzed by flow cytometry and chemical analyzer, respectively. The results show that ATRA significantly inhibited the growth of MiaPaCa-2 cells at 40 and 50 microM. ATRA arrested pancreatic cancer cells at G0/G1 phase. The sub-G1 peak and DNA fragmentation were observed. There were time and dose dependent increases in alkaline phosphatase activity (ALP), an indicator of cell differentiation, upon treatment with ATRA when compared to controls. In conclusion, ATRA has an inhibitory effect on the cell growth of MiaPaCa-2, and its tumor suppressive effect is by means of cell cycle arrest and apoptosis induction.


Subject(s)
Alkaline Phosphatase/metabolism , Cell Cycle/drug effects , Pancreatic Neoplasms/enzymology , Pancreatic Neoplasms/pathology , Tretinoin/pharmacology , Cell Line, Tumor , Flow Cytometry , Humans
3.
J Steroid Biochem Mol Biol ; 93(2-5): 183-90, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15860261

ABSTRACT

Epidemiological studies suggest that serum calcidiol (25(OH)-Vitamin D3) seems to be associated with several cancers including prostate cancer. We have made several experimental studies in order to clarify the mechanism(s) involved in the association. Calcidiol has been regarded as an inactive prohormone for calcitriol, which possesses the highest biological activity of the Vitamin D metabolites, when it is evaluated on the basis of bioactivity/nmol. However, we found recently that at the physiological concentration calcidiol (100-200 nM) is an active hormone, whereas calcitriol (1alpha,25(OH)2-Vitamin D3) (100 pM) is inactive in human primary prostate stromal cells. Calcidiol is able to inhibit cell growth and to induce or inhibit several genes including 1alpha-hydroxylase and 24-hydroxylase genes. This suggests that calcidiol might be an independent endocrine system involved in the control of cell differentiation and proliferation, whereas calcitriol might be mainly involved in the regulation of calcium and phosphorous balance. Several mechanisms may mediate the action of Vitamin D in the prostate. This is a review of some recent studies on the role of (1) Vitamin D metabolism, (2) growth factors and (3) fatty acid metabolism.


Subject(s)
Calcifediol/metabolism , Prostatic Neoplasms/metabolism , Calcitriol/metabolism , Cell Line, Tumor , Cell Proliferation , Fatty Acids/metabolism , Growth Substances/metabolism , Humans , Male , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/etiology , Prostatic Neoplasms/pathology , Signal Transduction , Vitamin D Deficiency/complications
4.
Physiol Behav ; 82(2-3): 405-9, 2004 Sep 15.
Article in English | MEDLINE | ID: mdl-15276805

ABSTRACT

Vitamin D is a neuroactive secosteroid with several important functions in the nervous system. Many human and animal findings link alterations in the vitamin D system to various neurological and behavioral disorders. Since grooming is an important element of animal behavior, here we studied whether genetic ablation of vitamin D receptors (VDR) in mice may be associated with altered grooming behaviors. Overall, VDR knockout (VDRko) mice presented longer duration and higher frequency of grooming when tested in the actimeter, open field, elevated plus maze, and horizontal rod tests. Increased grooming did not, however, correlate with unaltered general activity level (actimeter test), anxiety-like behaviors (hole board and elevated plus maze tests), and emotional reactivity index (defecation boli). In general, our results confirm the role of vitamin D and VDR in the regulation of behavior, including grooming, and suggest that increased grooming behavioral phenotype may be associated with genetic ablation of VDR in mutant mice.


Subject(s)
Behavior, Animal/physiology , Exploratory Behavior/physiology , Grooming/physiology , Receptors, Calcitriol/physiology , Animals , Anxiety/genetics , Anxiety/physiopathology , Male , Mice , Mice, Knockout , Receptors, Calcitriol/deficiency , Rotarod Performance Test , Time Factors
5.
J Steroid Biochem Mol Biol ; 92(4): 317-25, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15663995

ABSTRACT

Vitamin D deficiency increases risk of prostate cancer. According to our recent results, the key Vitamin D hormone involved in the regulation of cell proliferation in prostate is 25(OH) Vitamin D3. It is mainly acting directly through the Vitamin D receptor (VDR), but partially also through its 1alpha-hydroxylation in the prostate. A deficiency of 25(OH) Vitamin D is common especially during the winter season in the Northern and Southern latitudes due to an insufficient sun exposure, but Vitamin D deficient diet may partially contribute to it. A lack of Vitamin D action may also be due to an altered metabolism or Vitamin D resistance. Vitamin D resistance might be brought up by several mechanisms: Firstly, an increased 24-hydroxylation may increase the inactivation of hormonal Vitamin D metabolites resulting in a Vitamin D resistance. This is obvious in the cancers in which an oncogenic amplification of 24-hydroxykase gene takes place, although an amplification of this gene in prostate cancer has not yet been described. During the aging, the activity of 24-hydroxylase increases, whereas 1alpha-hydroxylation decreases. Furthermore, it is possible that a high serum concentration of 25(OH)D3 could induce 24-hydroxylase expression in prostate. Secondly, Vitamin D receptor gene polymorphism or defects may result in a partial or complete Vitamin D resistance. Thirdly, an overexpression or hyperphosphorylation of retinoblastoma protein may result in an inefficient mitotic control by Vitamin D. Fourthly, endogenous steroids (reviewed by [D.M. Peehl, D. Feldman, Interaction of nuclear receptor ligands with the Vitamin D signaling pathway in prostate cancer, J. Steroid Biochem. Mol. Biol. (2004)]) and phytoestrogens may modulate the expression of Vitamin D metabolizing enzymes. In summary, the local metabolism of hormonal Vitamin D seems to play an important role in the development and progression of prostate cancer.


Subject(s)
Cholecalciferol/metabolism , Prostatic Neoplasms/metabolism , 24,25-Dihydroxyvitamin D 3/blood , 24,25-Dihydroxyvitamin D 3/metabolism , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/genetics , 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/metabolism , Calcifediol/blood , Calcifediol/deficiency , Calcifediol/physiology , Calcitriol/pharmacology , Calcitriol/physiology , Cell Proliferation/drug effects , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Gene Expression Regulation, Neoplastic , Humans , Male , Phytoestrogens/pharmacology , Prostate/drug effects , Prostate/metabolism , Prostate/pathology , Prostatic Neoplasms/drug therapy , Prostatic Neoplasms/genetics , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Steroid Hydroxylases/antagonists & inhibitors , Steroid Hydroxylases/genetics , Steroid Hydroxylases/metabolism , Vitamin D3 24-Hydroxylase
6.
J Steroid Biochem Mol Biol ; 76(1-5): 125-34, 2001.
Article in English | MEDLINE | ID: mdl-11384870

ABSTRACT

Our recent epidemiological study (Ahonen et al., Cancer Causes Control 11(2000) (847-852)) suggests that vitamin D deficiency may increase the risk of initiation and progression of prostate cancer. The nested case-control study was based on a 13-year follow-up of about 19000 middle-aged men free of clinically verified prostate cancer. More than one-half of the serum samples had 25OH-vitamin D (25-VD) levels below 50 nmol/l, suggesting VD deficiency. Prostate cancer risk was highest among the group of younger men (40-51 years) with low serum 25-VD, whereas low serum 25-VD appeared not to increase the risk of prostate cancer in older men (>51 years). This suggests that VD has a protective role against prostate cancer only before the andropause, when serum androgen concentrations are higher. The lowest 25-VD concentrations in the younger men were associated with more aggressive prostate cancer. Furthermore, the high 25-VD levels delayed the appearance of clinically verified prostate cancer by 1.8 years. Since these results suggest that vitamin D has a protective role against prostate cancer, we tried to determine whether full spectrum lighting (FSL) during working hours could increase serum 25-VD concentrations. After 1-month exposure, there was no significant increase in the serum 25-VD level, although there was a bias towards slightly increasing values in the test group as opposed to decreasing values in controls. There was no significant change in the skin urocanic acid production. The possibility to use FSL in cancer prevention is discussed. In order to clarify the mechanism of VD action on cell proliferation and differentiation, we performed studies with the rat and human prostates as well prostate cancer cell lines. It is possible that 25-VD may have a direct role in the host anticancer defence activity, but the metabolism of vitamin D in the prostate may also play an important role in its action. We raised antibodies against human 1alpha-hydroxylase and 24-hydroxylase. Our preliminary results suggest that vitamin D is actively metabolised in the prostate. Vitamin D appears to upregulate androgen receptor expression, whereas androgens seem to upregulate vitamin D receptor (VDR). This may at least partially explain the androgen dependence of VD action. VD alone or administered with androgen causes a suppression of epithelial cell proliferation. VD can activate mitogen-activated kinases, erk-1 and erk-2, within minutes and p38 within hours. Also, auto/paracrine regulation might be involved, since keratinocyte growth factor (mRNA and protein) was clearly induced by VD. Based on these studies, a putative model for VD action on cell proliferation and differentiation is presented.


Subject(s)
Prostatic Neoplasms/etiology , Vitamin D Deficiency/complications , Vitamin D/analogs & derivatives , Adult , Amino Acid Sequence , Animals , Base Sequence , Cholestanetriol 26-Monooxygenase , Cytochrome P-450 Enzyme System/metabolism , DNA Primers , Fibroblast Growth Factor 7 , Fibroblast Growth Factors/genetics , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Middle Aged , Mitogen-Activated Protein Kinases/metabolism , Prostate/enzymology , Prostatic Neoplasms/blood , Prostatic Neoplasms/enzymology , Prostatic Neoplasms/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Steroid Hydroxylases/metabolism , Tumor Cells, Cultured , Vitamin D/blood , Vitamin D Deficiency/blood , Vitamin D Deficiency/enzymology , Vitamin D3 24-Hydroxylase
7.
Cancer Res ; 61(13): 5002-9, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11431333

ABSTRACT

Treatment of SKH-1 hairless mice with ultraviolet B light (UVB; 30 mJ/cm(2)) twice a week for 22 weeks resulted in tumor-free animals with a high risk of developing malignant and nonmalignant skin tumors during the next several months in the absence of additional UVB treatment (high-risk mice). Oral administration of green tea or black tea (6 mg tea solids/ml) to UVB-pretreated high-risk SKH-1 mice for 23 weeks after stopping UVB treatment decreased the number of tumors/mouse, decreased the size of the parametrial fat pads, and decreased the thickness of the dermal fat layer away from tumors and directly under tumors. Administration of the decaffeinated teas had little or no effect on these parameters, and adding caffeine (equivalent to the amount in the regular teas) to the decaffeinated teas restored their inhibitory effects. Administration of caffeine alone also decreased the number of tumors/mouse, the size of the parametrial fat pads, and the thickness of the dermal fat layer away from tumors and under tumors. Using data from individual mice and linear regression and correlation analysis, we found a highly significant positive correlation between the thickness of the dermal fat layer away from tumors and the number of tumors/mouse (r = 0.34; P = 0.0001), but the correlation between average tumor size/mouse and the thickness of the dermal fat layer away from tumors was weak (r = 0.16; P = 0.034). The results suggested that p.o. administered tea or caffeine may have decreased tumor multiplicity in part by decreasing fat levels in the dermis. Additional analysis revealed that oral administration of caffeinated beverages (green tea, black tea, decaffeinated green tea plus caffeine, decaffeinated black tea plus caffeine, or caffeine alone) decreased the thickness of the dermal fat layer under large tumors to a much greater extent than under small tumors. This is the first demonstration of a close association between inhibition of carcinogenesis and the lowering of tissue fat levels by a chemopreventive agent.


Subject(s)
Adipose Tissue/drug effects , Anticarcinogenic Agents/pharmacology , Caffeine/pharmacology , Skin Neoplasms/prevention & control , Tea , Ultraviolet Rays/adverse effects , Adipose Tissue/anatomy & histology , Adipose Tissue/metabolism , Administration, Oral , Animals , Beverages , Female , Mice , Mice, Hairless , Organ Size/drug effects , Skin Neoplasms/etiology , Skin Neoplasms/pathology
8.
Cancer Lett ; 168(2): 125-32, 2001 Jul 26.
Article in English | MEDLINE | ID: mdl-11403916

ABSTRACT

Dibenzoylmethane (DBM) is a minor constituent of licorice and a beta-diketone analogue of curcumin. Feeding 1% DBM in the diet to Sencar mice during both the initiation and the post-initiation periods strongly inhibited 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumor multiplicity and mammary tumor incidence by 97%. In further in vivo studies to elucidate the possible mechanisms of the inhibitory action of DBM, feeding the 1% DBM in the AIN-76A diet to immature Sencar mice for 4-5 weeks decreased the uterine wet weight by 43%, inhibited the proliferation rate of mammary gland epithelial cells by 53%, uterine epithelium by 23%, and uterine stroma by 77%, when mice were killed during the first estrus phase of estrous cycle. In addition, feeding 1% DBM in the diet to Sencar mice at 2 weeks before, during and 1 week after DMBA treatment (intubation of 1 mg DMBA per mouse once a week for 5 weeks) inhibited formation of total DMBA-DNA adducts in mammary glands by 72% using a post-32P-labeling assay. Thus, feeding 1% DBM diet to Sencar mice inhibited formation of DMBA-DNA adducts in mammary glands and lowered the proliferation rate of the mammary gland in vivo. These results may explain the strong inhibitory actions of dietary DBM on mammary carcinogenesis in mice.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/analogs & derivatives , 9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitors , Anticarcinogenic Agents/pharmacology , Benzoates/pharmacology , Carcinogens/antagonists & inhibitors , Chalcones , DNA Adducts/biosynthesis , Mammary Glands, Animal/drug effects , Mammary Neoplasms, Experimental/prevention & control , 9,10-Dimethyl-1,2-benzanthracene/metabolism , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Carcinogens/metabolism , Carcinogens/toxicity , Cell Division/drug effects , Diet , Female , Mammary Glands, Animal/cytology , Mammary Glands, Animal/metabolism , Mammary Neoplasms, Experimental/chemically induced , Mice , Mice, Inbred SENCAR , Organ Size/drug effects , Uterus/anatomy & histology , Uterus/cytology , Uterus/drug effects
9.
Cancer Res ; 60(17): 4785-91, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10987287

ABSTRACT

Pretreatment of SKH-1 mice with p.o.-administered 0.6% green tea (6 mg of lyophilized tea solids/ml) or 0.044% caffeine (0.44 mg/ml; concentration present in 0.6% green tea) for 2 weeks enhanced UV-induced increases in the number of p53-positive cells, p21(WAF1/CIP1)-positive cells, and apoptotic sunburn cells in the epidermis. These effects of p.o.-administered green tea or caffeine on early adaptive responses to UV provide the first demonstration of in vivo up-regulation of a tumor suppressor gene by a chemopreventive agent. The stimulatory effect of green tea and caffeine on UV-induced increases in the number of p53-positive cells, p21(WAF1/CIP1)-positive cells, and apoptotic sunburn cells may play a role in the inhibitory effects of tea and caffeine on UV-induced carcinogenesis.


Subject(s)
Anticarcinogenic Agents/pharmacology , Caffeine/pharmacology , Cyclins/biosynthesis , Epidermis/drug effects , Sunburn/metabolism , Tea , Tumor Suppressor Protein p53/biosynthesis , Adaptation, Biological/drug effects , Adaptation, Biological/radiation effects , Administration, Oral , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Bromodeoxyuridine/metabolism , Cell Division/drug effects , Cell Division/radiation effects , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , DNA/metabolism , Epidermis/metabolism , Epidermis/radiation effects , Female , Mice , Mice, Hairless , Stimulation, Chemical , Sunburn/pathology , Tumor Suppressor Protein p53/genetics , Ultraviolet Rays/adverse effects
10.
Cancer Res ; 59(18): 4591-602, 1999 Sep 15.
Article in English | MEDLINE | ID: mdl-10493513

ABSTRACT

Hairless SKH-1 mice were exposed once to UVB light (180 mJ/cm2), and mechanistically important early adaptive responses in the epidermis were evaluated by immunohistochemical and morphological methods. Interrelationships in the time course for these UVB-induced responses were examined. The number of epidermal cells with DNA strand breaks (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells) or with thymine dimers increased to maximal levels within 30 min after UVB. The number of cells with DNA strand breaks located specifically in the basal layer of the epidermis was increased substantially by 3-30 min after UVB and gradually increased further over the next 5.5 hours. DNA strand breaks specifically in the basal layer of the epidermis were increased maximally at 6 h after UVB. The number of epidermal cells with DNA strand breaks or thymine dimers decreased markedly between 12 and 36 h. Pyrimidine (6-4) pyrimidone photodimers (6-4 photoproducts) in isolated epidermal DNA were increased immediately after irradiation of the mice with UVB and decreased markedly during the next 6 h. Exposure to UVB caused a rapid 8-fold increase in the number of epidermal cells with the DNA mismatch repair protein, MSH2 (within 30-60 min), and the level of MSH2-positive cells remained elevated for at least 48 h. These observations suggest a possible role of MSH2 in the repair of UVB-induced DNA damage. The number of epidermal cells with wild-type p53 protein started to increase at 1 h after UVB exposure and reached maximal levels by 8-12 h. The number of p53-positive cells fell markedly between 24 and 48 h. The time course for UVB-induced increases in the number of p53-positive cells was paralleled very closely by the time course for UVB-induced increases in the number of cells with p21(WAF1/CIP1), increases in morphologically distinct apoptotic sunburn cells, and decreases in the number of epidermal cells with bromodeoxyuridine (BrdUrd) incorporation into DNA. Although the start of UVB-induced increases in the number of p21(WAF1/CIP1)-positive cells was similar to that for the increase in p53-positive cells and very high levels of p21(WAF1/CIP1)-positive cells were observed at 8-12 h, maximal increases in p21(WAF1/CIP1)-positive cells were not achieved until 24 h after UVB irradiation (approximately 12 h after the peak value for p53). Myeloperoxidase-positive epidermal cells started to increase by 30 min after UVB exposure, and maximal numbers of myeloperoxidase-positive epidermal cells were observed at 2 h after UVB (18-fold higher than in nonirradiated control mice). An increased level of epidermal peroxidase enzyme activity in the epidermis was also observed from 1 to 24 h after exposure of the mice to UVB. Although neutrophil infiltration into the epidermis was not seen after exposure to UVB, neutrophil infiltration into the dermis (inflammatory response) was observed from 4 to 144 h after UVB exposure. In contrast to the marked inhibitory effect of UVB on BrdUrd incorporation into the DNA of epidermal cells observed at 8-12 h after UVB irradiation (>90% inhibition), BrdUrd incorporation into the DNA of epidermal cells was markedly increased (approximately 30-fold increase in the number of BrdUrd-positive cells) at 48 h after UVB exposure, and increases in epidermal cell layers and epidermal thickness (hyperplasia) were also observed. These later effects were associated with regeneration of the damaged epidermis.


Subject(s)
DNA Damage , DNA-Binding Proteins , DNA/radiation effects , Epidermis/radiation effects , Skin/radiation effects , Ultraviolet Rays , Animals , Apoptosis/radiation effects , Ascorbic Acid/analysis , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/analysis , DNA/chemistry , DNA Repair , DNA Replication/radiation effects , Epidermis/pathology , Female , Glutathione/analysis , In Situ Nick-End Labeling , Mice , Mice, Hairless , MutS Homolog 2 Protein , Proto-Oncogene Proteins/analysis , Pyrimidine Dimers/analysis , Skin/pathology , Time Factors , Tumor Suppressor Protein p53/analysis
11.
Carcinogenesis ; 20(9): 1689-96, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10469612

ABSTRACT

Female CD-1 mice were treated topically with a low (25-50 nmol) or high (800 nmol) dose of benzo[a]pyrene (BP) or acetone vehicle, followed by 5 nmol 12-O-tetradecanoylphorbol 13-acetate (TPA) twice a week for 26 weeks. Selective UV radiation fractionation followed by PCR methods were used to analyze histologically defined subsets of cells (approximately 100-200 cells) on formalin-fixed, paraffin-embedded and H&E stained microscope sections. DNA samples from normal-appearing, hyperplastic or tumor regions from the skin of animals from each treatment group were isolated and amplified by PCR with c-Ha-ras-specific primers. Single-strand conformation polymorphism (SSCP) analyses were performed on both exon 1 and 2 products from each sample. DNA extracted from each aberrant band of SSCP analyses was amplified by PCR for further sequence analysis. The data indicate that c-Ha-ras mutations can be detected in normal-looking and hyperplastic epidermal cells as well as in tumor cells obtained from mice initiated with BP and promoted with TPA. The frequencies of c-Ha-ras mutations for normal-looking, hyperplastic and tumor samples were 3/20 (15%), 8/17 (47%) and 58/68 (85%), respectively, for the low dose group and 8/18 (44%), 10/20 (50%) and 64/86 (74%), respectively, for the high dose group. These observations indicate that there were no dose dependencies in the mutation frequencies for normal-looking, hyperplastic and tumor samples. For combined high dose and low dose samples, differences in mutation frequencies of the c-Ha-ras gene between the normal-looking, hyperplastic and tumor samples were highly significant (P < 0.0001, Fisher's exact test). All mutations detected were located at codons 12, 13 and 61 of the c-Ha-ras gene. With the numbers in parentheses indicating the nucleotide position in the coding sequence of the c-Ha-ras proto-oncogene, the distributions of mutations for G-->A (35), G-->T (35), G-->C (37), G-->T (38), C-->A (181), A-->T (182) and A-->G (182) in the low dose tumors were 5, 2, 11, 74, 0, 7 and 2%, respectively, and the distribution of mutations in tumors from animals treated with a high dose of BP were 3, 7, 13, 61, 15, 1 and 0%, respectively. Differences in the global mutation spectra (site and kind of all mutations) for the c-Ha-ras gene between the high and low dose group tumors were statistically significant (P < 0.004, Fisher's exact test) and the major difference between these two groups was C-->A (181) base substitutions. In summary, our data indicate that: (i) 79% of the BP/TPA skin tumors in CD-1 mice had c-Ha-ras mutations for the combined data for high dose and low dose tumors; (ii) the major mutations detected in BP/TPA skin tumors were G-->T transversions; (iii) the global mutation profile in the c-Ha-ras proto-oncogene in skin tumors obtained after initiation with a low dose of BP was different from that obtained after initiation with a high dose of BP.


Subject(s)
Benzo(a)pyrene/toxicity , Carcinogens/toxicity , Genes, ras , Papilloma/genetics , Proto-Oncogene Proteins p21(ras)/genetics , Skin Neoplasms/genetics , Administration, Cutaneous , Amino Acid Substitution , Animals , Benzo(a)pyrene/administration & dosage , Carcinogens/administration & dosage , Carcinoma in Situ/chemically induced , Carcinoma in Situ/genetics , Carcinoma in Situ/pathology , Cocarcinogenesis , Codon/genetics , DNA/genetics , DNA Mutational Analysis , DNA, Neoplasm/genetics , Dose-Response Relationship, Drug , Epidermis/drug effects , Epidermis/pathology , Exons/genetics , Female , Hyperplasia , Keratoacanthoma/chemically induced , Keratoacanthoma/genetics , Keratoacanthoma/pathology , Mice , Papilloma/chemically induced , Papilloma/pathology , Point Mutation , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , Skin Neoplasms/chemically induced , Skin Neoplasms/pathology , Tetradecanoylphorbol Acetate/toxicity
12.
Nutr Cancer ; 33(2): 146-53, 1999.
Article in English | MEDLINE | ID: mdl-10368809

ABSTRACT

Treatment of SKH-1 mice with ultraviolet B light (UV-B, 30 mJ/cm2) twice a week for 22-23 weeks resulted in tumor-free animals with a high risk of developing malignant and nonmalignant tumors during the next several months in the absence of further UV-B treatment (high-risk mice). In three separate experiments, oral administration of green tea or black tea (4-6 mg tea solids/ml) as the sole source of drinking fluid for 18-23 weeks to these high-risk mice inhibited the formation and decreased the size of nonmalignant squamous cell papillomas and keratoacanthomas as well as the formation and size of malignant squamous cell carcinomas. In one experiment all these inhibitory effects of tea were statistically significant, whereas in the two other experiments many but not all of the inhibitory effects of tea were statistically significant. The decaffeinated teas were inactive or less effective inhibitors of tumor formation than the regular teas, and adding caffeine back to the decaffeinated teas restored biological activity. Oral administration of caffeine alone (0.44 mg/ml) as the sole source of drinking fluid for 18-23 weeks inhibited the formation of nonmalignant and malignant tumors, and this treatment also decreased tumor size in these high-risk mice.


Subject(s)
Anticarcinogenic Agents/pharmacology , Caffeine/pharmacology , Carcinoma, Squamous Cell/prevention & control , Keratoacanthoma/prevention & control , Neoplasms, Radiation-Induced/prevention & control , Papilloma/prevention & control , Skin Neoplasms/prevention & control , Tea , Administration, Oral , Animals , Anticarcinogenic Agents/administration & dosage , Caffeine/administration & dosage , Carcinoma, Squamous Cell/pathology , Female , Keratoacanthoma/pathology , Mice , Mice, Hairless , Neoplasms, Radiation-Induced/pathology , Papilloma/pathology , Skin Neoplasms/pathology , Ultraviolet Rays/adverse effects
13.
Carcinogenesis ; 19(9): 1697-700, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9771944

ABSTRACT

Female Sencar mice (6 weeks old) were administered 1 mg of 7,12-dimethylbenz[a]anthracene (DMBA) by oral gavage once a week for 5 weeks. At 20 weeks after the first dose of DMBA, 68% of mice developed mammary tumors (the average 1.08 tumors per mouse) and 45% had lymphomas/leukemias. Feeding 1% dibenzoylmethane (DBM) in AIN 76A diet, starting at 2 weeks before the first dose of DMBA and continuing until the end of the experiment, inhibited both the multiplicity and incidence of DMBA-induced mammary tumor by 97%. The incidence of lymphomas/leukemias was completely inhibited by 1% DBM diet. In contrast, feeding 2% curcumin diet had little or no effect on the incidence of mammary tumors, and the incidence of lymphomas/leukemias was reduced by 53%.


Subject(s)
Anticarcinogenic Agents/pharmacology , Benzoates/pharmacology , Chalcones , Curcumin/pharmacology , Leukemia, Experimental/prevention & control , Lymphoma/prevention & control , Mammary Neoplasms, Experimental/prevention & control , 9,10-Dimethyl-1,2-benzanthracene , Animals , Female , Leukemia, Experimental/chemically induced , Lymphoma/chemically induced , Mammary Neoplasms, Experimental/chemically induced , Mice
14.
Carcinogenesis ; 19(7): 1257-62, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9683186

ABSTRACT

In the present study, administration of green tea to SKH-1 mice, via the drinking fluid, was found to significantly reduce the incidence and volume of ultraviolet B (UVB) radiation-induced skin tumors. Thirty-six skin tumors induced by UVB and 32 skin tumors induced by UVB, in mice treated with green tea in their drinking water, were collected and examined for the presence of mutations in the p53 gene. Polymerase chain reaction products from p53 exons 5-8 were screened by single-strand conformation polymorphism and direct sequence analyses. Eight of 36 UVB-induced tumors contained nine p53 mutations, with four in exon 5 and five in exon 8. In contrast, nine of 32 UVB-induced tumors in mice treated with green tea contained 11 p53 mutations, with two in exon 5, five in exon 6 and four in exon 8. All of the p53 mutations occurred at dipyrimidine sequences. These results were further corroborated by p53 immunohistochemistry. The most frequent mutations were C-->T or T-->C transitions, which are consistent with the genetic alterations caused by UVB exposure. Interestingly, mutations found in exon 6 of the p53 gene occurred only in tumors from the UVB/green tea group. Thus, the tumors observed in UVB/green-tea-treated mice have a different exon distribution of p53 mutations than tumors obtained from mice treated with UVB alone.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Genes, p53 , Mutation , Neoplasms, Radiation-Induced/genetics , Neoplasms, Radiation-Induced/prevention & control , Skin Neoplasms/genetics , Skin Neoplasms/prevention & control , Tea , Ultraviolet Rays/adverse effects , Animals , Carcinoma, Large Cell/etiology , Carcinoma, Large Cell/genetics , Carcinoma, Large Cell/prevention & control , Carcinoma, Squamous Cell/etiology , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/prevention & control , Codon , Exons , Female , Immunohistochemistry , Mice , Mice, Hairless , Neoplasms, Radiation-Induced/etiology , Polymerase Chain Reaction , Skin Neoplasms/etiology , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism
15.
Carcinogenesis ; 18(11): 2163-9, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9395217

ABSTRACT

Female CD-1 mice were initiated with a single topical application of 7,12-dimethylbenz[a]anthracene and promoted with 12-O-tetradecanoylphorbol-13-acetate. Mice with established papillomas were then treated with black tea or decaffeinated black tea (approximately 4 mg tea solids/ml) as the sole source of drinking fluid for 11-15 weeks. In four separate experiments, oral administration of black tea inhibited the growth of papillomas (increase in tumor volume/mouse) by an average of 35%, 37%, 41% and 48%, respectively. Studies with decaffeinated black tea gave inconsistent results. In one experiment, administration of decaffeinated black tea inhibited papilloma growth (increase in tumor volume/mouse) by 27%, but in two additional experiments papilloma growth was stimulated by 14% and 193%, respectively. In a separate experiment, skin tumors were generated by treating SKH-1 female mice with ultraviolet B light (UVB; 30 mJ/cm2) twice weekly for 22 weeks, after which UVB administration was stopped. Tumors were allowed to develop during the following 13 weeks, and tumor-bearing mice were then treated with black tea (6 mg/ml tea solids) as the drinking fluid for 11 weeks. In this experiment, tumor growth (increase in tumor volume/mouse) was inhibited by 70%. Histological examination revealed that tea-treated mice had a 58% decrease in the number of nonmalignant tumors (primarily keratoacanthomas)/mouse and a 54% decrease in the number of squamous cell carcinomas/mouse. In addition, administration of black tea decreased the volume per tumor by 60% for nonmalignant tumors and by 84% for carcinomas. Mechanistic studies with tumors from these mice revealed that administration of black tea decreased the bromodeoxyuridine labeling index in squamous cell papillomas, keratoacanthomas and squamous cell carcinomas by 56%, 45% and 35%, respectively, and the apoptosis index was increased by 44%, 100% and 95%, respectively. Administration of black tea decreased the mitotic index in keratoacanthomas and squamous cell carcinomas by 42% and 16%, respectively. The results indicate that oral administration of black tea to tumor-bearing mice inhibited proliferation and enhanced apoptosis in nonmalignant and malignant skin tumors.


Subject(s)
Apoptosis , Bromodeoxyuridine/metabolism , DNA/biosynthesis , Mitosis , Skin Neoplasms/therapy , Tea , 9,10-Dimethyl-1,2-benzanthracene , Animals , Carcinoma, Squamous Cell/therapy , Female , Keratoacanthoma/therapy , Mice , Papilloma/therapy , Skin Neoplasms/pathology , Ultraviolet Rays
16.
Cancer Res ; 57(13): 2623-9, 1997 Jul 01.
Article in English | MEDLINE | ID: mdl-9205068

ABSTRACT

Oral administration of green or black tea inhibited UVB light-induced complete carcinogenesis in the skin of SKH-1 mice. Green tea was a more effective inhibitor than black tea. Oral administration of decaffeinated green or black tea resulted in substantially less inhibitory activity than did administration of the regular teas, and in one experiment, administration of a high-dose level of the decaffeinated teas enhanced the tumorigenic effect of UVB. Oral administration of caffeine alone had a substantial inhibitory effect on UVB-induced carcinogenesis, and adding caffeine to the decaffeinated teas restored the inhibitory effects of these teas on UVB-induced carcinogenesis. In additional studies, topical application of a green tea polyphenol fraction after each UVB application inhibited UVB-induced tumorigenesis. The results indicate that caffeine contributes in an important way to the inhibitory effects of green and black tea on UVB-induced complete carcinogenesis.


Subject(s)
Caffeine/pharmacology , Flavonoids , Neoplasms, Radiation-Induced/prevention & control , Skin Neoplasms/prevention & control , Tea/chemistry , Ultraviolet Rays/adverse effects , Administration, Oral , Animals , Carcinoma, Squamous Cell/etiology , Carcinoma, Squamous Cell/prevention & control , Female , Keratoacanthoma/etiology , Keratoacanthoma/prevention & control , Mice , Mice, Inbred Strains , Papilloma/etiology , Papilloma/prevention & control , Phenols/administration & dosage , Polymers/administration & dosage , Polyphenols , Skin Diseases/etiology , Skin Diseases/prevention & control , Skin Neoplasms/etiology
17.
Cancer Res ; 57(8): 1468-74, 1997 Apr 15.
Article in English | MEDLINE | ID: mdl-9108447

ABSTRACT

Female transgenic mice (C57BL/6 x CBA/J)F1 with a 1-fold increase in expression of glutathione peroxidase (GP) or with a 1-fold increase in the expression of GP and a 3-4-fold increase in the expression of superoxide dismutase (SOD) had an enhanced carcinogenic response to initiation by 7,12-dimethylbenz[a]anthracene (DMBA) followed by promotion with 12-O-tetradecanoylphorbol-13-acetate (TPA). GP- or GP+SOD-transgenic mice that were initiated by a single topical application of 200 nmol of DMBA followed by promotion with 8 nmol of TPA twice weekly for 30 weeks developed an average of 10.9 or 11.0 skin tumors per mouse and a 100% tumor incidence in comparison with the corresponding nontransgenic mice, which had 3.9 tumors per mouse and an 83% tumor incidence. After stopping TPA application, partial skin tumor regression occurred more rapidly in nontransgenic mice than in either type of transgenic mouse. At 10 weeks after termination of TPA treatment, 9-11% of the tumor-bearing transgenic mice and 26% of the tumor-bearing nontransgenic mice had complete regression of their tumors. Histopathological examination of 96 skin papillomas revealed that the area, location, degree of tumor dysplasia, bromodeoxyuridine labeling index, and p53 protein levels were closely intercorrelated. Further analysis indicated that papillomas with the same grade of dysplasia had a higher bromodeoxyuridine labeling index and a greater p53 protein level in GP- or GP+SOD-transgenic mice than those in nontransgenic mice. The data indicated that overexpression of skin antioxidant enzymes GP or GP+SOD, which are enzymes that are believed to protect cells from oxidative damage by scavenging reactive oxygen species, lead to the increased, rather than the decreased, tumorigenesis in a DMBA/TPA two-stage skin carcinogenesis model.


Subject(s)
Glutathione Peroxidase/metabolism , Papilloma/chemically induced , Papilloma/metabolism , Skin Neoplasms/chemically induced , Skin Neoplasms/enzymology , Skin/metabolism , Superoxide Dismutase/metabolism , 9,10-Dimethyl-1,2-benzanthracene , Animals , Bromodeoxyuridine/metabolism , Carcinogens , DNA/metabolism , Female , Humans , Immunohistochemistry , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , Papilloma/pathology , Skin/drug effects , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Tetradecanoylphorbol Acetate , Tumor Suppressor Protein p53/analysis
18.
Proc Soc Exp Biol Med ; 216(2): 234-45, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9349692

ABSTRACT

Topical application of curcumin inhibits chemically induced carcinogenesis on mouse skin, and oral administration of curcumin inhibits chemically induced oral, forestomach, duodenal, and colon carcinogenesis. Curcumin and other inhibitors of cyclooxygenase and lipoxygenase are thought to inhibit carcinogenesis by preventing the formation of arachidonic acid metabolites. In contrast to our expectation of a tumorigenic effect of arachidonic acid, we found that treatment of 7,12-dimethylbenz[a]anthracene-initiated mouse skin with very high doses of arachidonic acid twice daily, 5 days a week for 26 weeks, failed to result in tumors. We considered the possibility that some of the cancer chemopreventive effects of curcumin may be related to an effect of this compound on cellular differentiation, and we investigated the effect of curcumin on differentiation in the human promyelocytic HL-60 leukemia cell model system. Although curcumin alone had little or no effect on cellular differentiation, when it was combined with all-trans retinoic acid or 1alpha,25-dihydroxyvitamin D3 a synergistic effect was observed. It is possible that many dietary chemicals in fruits, vegetables, and other edible plants can prevent cancer by synergizing with endogenously produced stimulators of differentiation such as all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and butyrate. More research is needed to test this hypothesis. Administration of green or black tea inhibits carcinogenesis in several animal models, and tumor growth is also inhibited. Several examples were presented of chemopreventive agents that inhibit carcinogenesis in one animal model but enhance carcinogenesis in a different animal model. Greater efforts should be made to understand mechanisms of cancer chemoprevention and to determine whether a potential chemopreventive agent is useful in many experimental settings or whether it is useful in only a limited number of experimental settings.


Subject(s)
Anticarcinogenic Agents , Curcumin/pharmacology , Diet , Neoplasms, Experimental/prevention & control , Tea , Animals , Arachidonic Acid/metabolism , Arachidonic Acid/pharmacology , Calcitriol/therapeutic use , Carcinogens/pharmacology , Cell Differentiation/drug effects , Chemoprevention , Curcumin/administration & dosage , Curcumin/analogs & derivatives , Humans , Mice , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/therapy , Tea/chemistry , Tetradecanoylphorbol Acetate/pharmacology , Tretinoin/pharmacology
19.
Cancer Res ; 54(22): 5841-7, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7954412

ABSTRACT

Curcumin (diferuloylmethane), a yellow pigment that is obtained from the rhizomes of Curcuma longa Linn., is a major component of turmeric and is commonly used as a spice and food-coloring agent. The inhibitory effects of feeding commercial grade curcumin (77% curcumin, 17% demethoxycurcumin, and 3% bisdemethoxycurcumin) in AIN 76A diet on carcinogen-induced tumorigenesis in the forestomach, duodenum, and colon of mice were evaluated. Administration p.o. of commercial grade curcumin in the diet inhibited benzo(a)pyrene-induced forestomach tumorigenesis in A/J mice, N-ethyl-N'-nitro-N-nitrosoguanidine-induced duodenal tumorigenesis in C57BL/6 mice, and azoxymethane (AOM)-induced colon tumorigenesis in CF-1 mice. Dietary commercial grade curcumin was given to mice at: (a) 2 weeks before, during, and for 1 week after carcinogen administration (during the initiation period); (b) 1 week after carcinogen treatment until the end of the experiment (during the postinitiation period); or (c) during both the initiation and postinitiation periods. Feeding 0.5-2.0% commercial grade curcumin in the diet decreased the number of benzo(a)pyrene-induced forestomach tumors per mouse by 51-53% when administered during the initiation period and 47-67% when administered during the postinitiation period. Feeding 0.5-2.0% commercial grade curcumin in the diet decreased the number of N-ethyl-N'-nitro-N-nitrosoguanidine-induced duodenal tumors per mouse by 47-77% when administered during the postinitiation period. Administration of 0.5-4.0% commercial grade curcumin in the diet both during the initiation and postinitation periods decreased the number of AOM-induced colon tumors per mouse by 51-62%. Administration of 2% commercial grade curcumin in the diet inhibited the number of AOM-induced colon tumors per mouse by 66% when fed during the initiation period and 25% when fed during the postinitiation period. The ability of commercial grade curcumin to inhibit AOM-induced colon tumorigenesis is comparable to that of pure curcumin (purity greater than 98%). Administration of pure or commercial grade curcumin in the diet to AOM-treated mice resulted in development of colon tumors which were generally smaller in number and size as compared to the control group of AOM-treated mice. These results indicate that not only did curcumin inhibit the number of tumors per mouse and the percentage of mice with tumors but it also reduced tumor size. Histopathological examination of the tumors showed that dietary curcumin inhibited the number of papillomas and squamous cell carcinomas of the forestomach as well as the number of adenomas and adenocarcinomas of the duodenum and colon.


Subject(s)
Colonic Neoplasms/prevention & control , Curcumin/pharmacology , Duodenal Neoplasms/prevention & control , Stomach Neoplasms/prevention & control , Adenocarcinoma/chemically induced , Adenocarcinoma/prevention & control , Adenoma/chemically induced , Adenoma/prevention & control , Adenoma, Villous/chemically induced , Adenoma, Villous/prevention & control , Animals , Azoxymethane , Benzo(a)pyrene , Carcinogens , Colonic Neoplasms/chemically induced , Curcumin/administration & dosage , Duodenal Neoplasms/chemically induced , Female , Male , Methylnitronitrosoguanidine/analogs & derivatives , Mice , Stomach Neoplasms/chemically induced
20.
Carcinogenesis ; 15(10): 2363-70, 1994 Oct.
Article in English | MEDLINE | ID: mdl-7955078

ABSTRACT

Expression of c-jun protein (c-Jun) was observed in normally proliferating JB6 cells but not in confluent cells. Reduction of the serum concentration from 5% to 2% in the cell culture medium caused JB6 cells to enter a quiescent non-proliferating state and down-regulated the expression of c-Jun. Treatment of quiescent JB6 cells with 12-O-tetradecanoylphorbol-13-acetate (TPA) (10 ng/ml) for 24 h markedly stimulated the formation of c-Jun and caused morphological changes. Treatment of JB6 cells with TPA for 48 h resulted in transformed foci with mixed cell populations. Although some cells in these foci expressed high levels of c-Jun, many other cells did not. The increased expression of c-Jun and morphological changes observed at 24 h after treatment of JB6 cells with TPA (10 ng/ml) was inhibited by curcumin (10 nmol/ml). Treatment of JB6 cells with 2.5, 5 or 10 nmol curcumin/ml inhibited the formation of TPA-induced anchorage-independent colonies that grow in soft agar by 31%, 43% and 77%, respectively. Although inhibition of cell proliferation was not observed with 2.5 nmol curcumin/ml, higher concentrations did inhibit cell proliferation. Topical application of 5 nmol TPA to the backs of CD-1 mice once a day for 5 days caused epidermal hyperplasia and the levels of c-Jun were increased in the suprabasal layer of the epidermis and in the muscle layer of the dermis. This treatment also increased c-fos protein (c-Fos) expression in the muscle layer, but there was little or no increase in the expression of c-Fos in the basal or suprabasal layer of the epidermis. Topical application of 10 mumol curcumin together with 5 nmol TPA once a day for 5 days strongly inhibited TPA-induced epidermal hyperplasia and c-Jun and c-Fos expression. A single application of 180 mJ/cm2 of ultraviolet B light (UVB) to the backs of SKH-1 mice caused epidermal hyperplasia and expression of c-Fos and c-Jun in the muscle layer of the dermis and of c-Fos in the suprabasal layer of the epidermis. Maximum effects were observed at 6 days after UVB exposure. Application of 10 mumol curcumin to mouse skin twice a day for 5 days immediately after UVB exposure had only a small/variable inhibitory effect on UVB-induced increases in the expression of c-Fos and c-Jun and on epidermal hyperplasia.(ABSTRACT TRUNCATED AT 400 WORDS)


Subject(s)
Cocarcinogenesis , Curcumin/pharmacology , Proto-Oncogene Proteins c-fos/biosynthesis , Proto-Oncogene Proteins c-jun/biosynthesis , Skin/drug effects , Skin/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Ultraviolet Rays , Animals , Cell Division/drug effects , Cell Transformation, Neoplastic , Cells, Cultured , Drug Interactions , Female , Gene Expression Regulation/drug effects , Hyperplasia , Mice , Mice, Hairless , Proto-Oncogene Proteins c-fos/analysis , Proto-Oncogene Proteins c-jun/analysis , Skin/radiation effects , Skin Neoplasms/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...